Attendance Grant - European Society of Clinical Microbiology and Infectious Diseases supports scientists attending educational and scientific events to advance learning and professional development.
Attendance-grant applications are now open until 17 December 2026 for “Clinical trials in phage therapy: generating evidence to enable regulatory approval and clinical use,” taking place in Rome, Italy, on 11–12 February 2027.
Funder: European Society of Clinical Microbiology and Infectious Diseases
Due Dates: December 17, 2026 (Phage therapy course attendance grant) | Other events: see individual event pages
Funding Amounts: Event registration fee, unless otherwise specified; travel and separate accommodation excluded
Summary: Supports scientists attending ESCMID-organised or endorsed educational and scientific events through registration-fee coverage.
Key Information: Applicants must be ESCMID Full members, including Young Scientist Members and members from low- or lower-middle-income countries.
The ESCMID Attendance Grant supports scientists wishing to attend educational and scientific events organised or endorsed by the European Society of Clinical Microbiology and Infectious Diseases. It funds event attendance rather than a standalone research project, helping members access learning and professional development in clinical microbiology and infectious diseases.
Supported opportunities include onsite courses and workshops, the Antimicrobial Stewardship (AMS) Certificate Programme, Ecraid-base training opportunities, the EUCIC Infection Prevention and Control Certificate, and ESCMID Summer School. ESCMID’s postgraduate courses address specific clinical and laboratory topics, while its certificate programmes offer training in antimicrobial stewardship and infection prevention and control. Grant availability and application timeframes depend on the individual event.